CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
intraarticular injectiondrug
Likely dose
intraarticular injection 60mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00506896
NCT00506896Phase 2Completed
CompareCT.gov

Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients: A Randomized Double-Blind Controlled Study

Federal University of São Paulo·interventional·Posted Jul 25, 2007·Updated Jul 25, 2007

In Brief

A Phase 2 clinical trial evaluating intraarticular injection for Rheumatoid Arthritis. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the efficacy and safety of intra-articular glucocorticoid injection to its systemic use for treatment of knee synovitis in patients with Rheumatoid Arthritis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesBrazil
Collaborators--

Timeline

Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 25, 2007
Enrollment StartJul 1, 2004
Study CompletionJan 1, 2006
TodayJul 2, 2026
Posted 18.9 years ago

Interventions

intraarticular injectiondrug

Triamcinolone hexacetonide 60mg(3ml)by intraarticular injection Triamcinolone acetonide 60mg (3ml)by intramuscular administration